REQUEST A DEMO
Total
USD $0.00
Search more companies

Jeil Pharma Holdings Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jeil Pharma Holdings Inc. Profile Updated: September 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Jeil Pharmaceutical Co.,Ltd is a pharmaceutical company operating in the pharmaceutical industry, offering healthcare solutions to the market. The company has an MR organization covering the South Korean market and exports its products to over 40 countries. The company has research laboratories for the invention of New Molecule Entities (NMEs) and the development of Active Pharmaceutical Ingredients (APIs). Jeil Pharmaceutical Co.,Ltd. also operates manufacturing facilities for Oral Solid Dosage (OSD) forms and has overseas sales turnover exceeding 60 million US dollars.

Headquarters
745-5 Banpo-Dong, Seocho-Gu
Seoul; Seoul; Postal Code: 137-040

Contact Details: Purchase the Jeil Pharma Holdings Inc. report to view the information.

Website: http://www.jeilpharm.co.kr

Basic Information
Total Employees:
Purchase the Jeil Pharma Holdings Inc. report to view the information.
Outstanding Shares:
Purchase the Jeil Pharma Holdings Inc. report to view the information.
Registered Capital:
Purchase the Jeil Pharma Holdings Inc. report to view the information.
Financial Auditors:
Purchase the Jeil Pharma Holdings Inc. report to view the information.
Incorporation Date:
March 07, 1959
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
27.31%
Purchase this report to view the information.
8.33%
Purchase this report to view the information.
4.66%
Purchase this report to view the information.
2.76%
Purchase this report to view the information.
2.4%
Subsidiaries
제일파마홀딩스(주)
Company Performance
Financial values in the chart are available after Jeil Pharma Holdings Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
1.4%
Total operating revenue
1.47%
Operating profit (EBIT)
95.46%
EBITDA
364.66%
Net Profit (Loss) for the Period
84.08%
Total assets
1.65%
Total equity
-4.19%
Operating Profit Margin (ROS)
9.94%
Net Profit Margin
8.84%
Return on Equity (ROE)
16.52%
Debt to Equity Ratio
7.06%
Quick Ratio
-0.04%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?